Therefore, impacts from this incident are not associated with DDC.
This system has never been used in DDC’s operations and has not been active since 2012. The impacted database was associated with a national genetic testing organization system that DDC acquired in 2012. (DDC) detected potential unauthorized access to its network, during which there was unauthorized access and acquisition of an archived database that contained personal information collected between 20. What happened? On August 6, 2021, DNA Diagnostics Center, Inc.
We will keep this page updated with actions we are taking, including free credit monitoring and identity theft protection services for those whose personal information was potentially accessed. We have obtained a copy of the initial data breach letter issued by DNA Diagnostics Center, Inc.:ĭata Security Incident Information Center - DDC More about what you can do if your data was stolen is available in our prior blog post, " A Guide For Victims of a Data Breach ”. If you received a data breach notification, it is essential you understand what is at risk and what you can do about it. began sending out data breach notification letters to those affected by the security breach. On November 29, 2021, DNA Diagnostics Center, Inc. Varying by patient, the information accessed may include patients’ Social Security numbers. detected unauthorized access to their network gaining access to sensitive information belonging to approximately 2,102,436 individuals. On August 6, 2021, DNA Diagnostics Center, Inc.
To embed, copy and paste the code into your website or blog: SOURCE DNA Diagnostics Center, Inc.Data Breach Update: DNA Diagnostics Center, Inc. For more information visit: Contact: Dave Silver ContraVac's SpermCheck products were developed in collaboration with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia and Princeton BioMeditech Corporation. For more information visit About ContraVac, Inc:ĬontraVac, Inc., a privately held biotechnology company located in Charlottesville, VA, develops over-the-counter fertility products to meet the needs of millions of men who seek actionable information about their fertility health and wish to test themselves in the privacy of their home.
DDC is also accredited by ACLASS to meet the international standards of ISO 17025 and the American Society of Crime Laboratory Directors / Laboratory Accreditation Board-International (ASCLD/LAB). DDC® offers DNA testing for paternity and family relationships, forensics, genetic traits of animals, and ancestry.ĭDC® is accredited by the American Association of Blood Banks (AABB), The Ministry of Justice, The College of American Pathologists (CAP), and The Clinical Laboratory Improvement Amendment (CLIA).
Leary will join DDC® via the acquisition.ĭNA Diagnostics Center ® (DDC®), founded over twenty years ago, is one of the world's largest private DNA testing companies with offices in Fairfield, Ohio ( United States) and London, England (United Kingdom). DDC's worldwide sales, marketing and distribution networks will enable us to create global awareness of the frequency of male factor infertility, accounting for up to 50% of couple infertility, and increase the availability of SpermCheck® Fertility for couples who have been trying to conceive without success." Mr. commented "We are pleased to have the SpermCheck® products in the DDC® product portfolio. They have built a strong brand that consumers trust as the global leader in home male fertility testing."Įd Leary, Chief Executive Officer of ContraVac, Inc.
Connie Hallquist, President and Chief Executive Officer of DNA Diagnostics Center®, states: "We are excited about the acquisition of ContraVac, Inc.